Pelvic Floor Muscle Training and Biofeedback or Standard Therapy in Men Who Have Undergone Radical Prostatectomy or Transurethral Resection of the Prostate
Primary Purpose
Nonmalignant Neoplasm, Prostate Cancer, Psychosocial Effects of Cancer and Its Treatment
Status
Completed
Phase
Phase 3
Locations
United Kingdom
Study Type
Interventional
Intervention
exercise intervention
questionnaire administration
biofeedback
management of therapy complications
psychosocial assessment and care
quality-of-life assessment
Sponsored by
About this trial
This is an interventional supportive care trial for Nonmalignant Neoplasm focused on measuring sexual dysfunction, psychosocial effects of cancer and its treatment, prostate cancer, benign prostatic hyperplasia, urinary incontinence
Eligibility Criteria
DISEASE CHARACTERISTICS:
- Men who have undergone a radical prostatectomy for prostate cancer or men who have undergone a transurethral resection of the prostate for benign prostatic hypertrophy
Urinary incontinence at six weeks after prostate surgery
- Incontinence is defined as a response on the screening questionnaire indicating a loss of urine including how often and how much
PATIENT CHARACTERISTICS:
- Able to comply with intervention
- Able to complete study questionnaires
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
- No referral for formal therapy (teaching of pelvic floor muscle training) due to prostate surgery
- No concurrent or planned radiotherapy during the first 3 months after surgery
- No palliative endoscopic resection of prostate due to outflow obstruction for advanced prostate cancer
Sites / Locations
- Tameside General Hospital
- Southmead Hospital
- Bristol Royal Infirmary
- Mid Cheshire Hospitals Trust- Leighton Hopsital
- Royal Bolton Hospital
- King George Hospital
- Ipswich Hospital
- Airedale General Hospital
- Leeds Cancer Centre at St. James's University Hospital
- St. Mary's Hospital
- Macclesfield District General Hospital
- James Cook University Hospital
- Freeman Hospital
- Norfolk and Norwich University Hospital
- Nottingham City Hospital
- Berkshire Cancer Centre at Royal Berkshire Hospital
- Queens Hospital
- Hope Hospital
- Royal Hallamshire Hospital
- Lister Hospital
- Stepping Hill Hospital
- Taunton and Somerset Hospital
- Hillingdon Hospital
- New Cross Hospital
- Yeovil District Hospital
- Aberdeen Royal Infirmary
- Ayr Hospital
- Ninewells Hospital
- Queen Margaret Hospital - Dunfermline
- Edinburgh Cancer Centre at Western General Hospital
- Falkirk and District Royal Infirmary
- Southern General Hospital
- Inverclyde Royal Hospital
- Raigmore Hospital
- Pinderfields General Hospital
- Morriston Hospital NHS Trust
- University Hospital of Wales
Outcomes
Primary Outcome Measures
Subjective report of urinary continence at 12 months
Incremental cost per quality-adjusted year
Secondary Outcome Measures
Subjective report of continence or improvement of urinary incontinence at 3, 6, and 9 months after randomization and improvement at 12 months
Objective report of the number of incontinent episodes in the previous week from the urinary diary
Duration of incontinence based on time of resolution relative to time of operation and randomization
Use of absorbent pads, penile collecting sheath, bladder catheter, or bed/chair pads
Number and type of incontinence products used
Co-existence, cure or development of urgency, or urge incontinence
Urinary frequency
Nocturia
Fecal incontinence (passive or urge)
Other bowel dysfunction (i.e., urgency, constipation, or other bowel diseases)
Sexual function at 12 months including information about erection, ejaculation, retrograde ejaculation, pain, change in sex life, and reason for change
Incontinence-specific quality of life outcome measure using the 10-point scale and ICI questionnaire
General health measures
Need for alternative management for incontinence (e.g., surgery or drugs)
Use of GP, nurse, consultant urologist, or physiotherapist
Visits to GP
Visits to practice nurse
Use of pelvic floor muscle training
Lifestyle changes (i.e., weight, constipation, lifting, coughing, or exercise)
Patient costs (e.g., self care [e.g., pads or laundry], travel to health services, or sick leave)
Cost of conservative trial treatment
Cost of alternative or additional NHS treatments (e.g., pads, catheters, drugs [e.g., adrenergic agonists, anticholinergics, or oral medication for erectile dysfunction], hospital admissions, or further surgery)
Other measures of cost-effectiveness (e.g., incremental cost per additional man continent at 12 months)
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT00632138
Brief Title
Pelvic Floor Muscle Training and Biofeedback or Standard Therapy in Men Who Have Undergone Radical Prostatectomy or Transurethral Resection of the Prostate
Official Title
MAPS (Men After Prostate Surgery) : Conservative Treatment for Men With Urinary Incontinence After Prostate Surgery; Multicentre Randomised Controlled Trial of Pelvic Floor Muscle Training and Biofeedback [MAPS]
Study Type
Interventional
2. Study Status
Record Verification Date
December 2008
Overall Recruitment Status
Completed
Study Start Date
January 2005 (undefined)
Primary Completion Date
December 2008 (Actual)
Study Completion Date
July 2011 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Aberdeen Royal Infirmary
4. Oversight
5. Study Description
Brief Summary
RATIONALE: Personalized training by a health professional may improve urinary incontinence. It is not yet known whether pelvic floor muscle training and biofeedback are more effective than standard therapy in improving urinary continence after radical prostatectomy or transurethral resection of the prostate.
PURPOSE: This randomized phase III trial is studying pelvic floor muscle training and biofeedback to see how well it works compared with standard therapy in men who have undergone radical prostatectomy or transurethral resection.
Detailed Description
OBJECTIVES:
To establish whether conservative physical treatment delivered personally by a trained health professional results in better urinary and other outcomes compared with standard management in men who are incontinence after prostate surgery.
OUTLINE: This is a multicenter study. Patients are stratified according to type of operation (radical prostatectomy vs transurethral resection of prostate). Patients are randomized to 1 of 2 treatment arms.
Arm I (intervention group): At 6 weeks after surgery, patients undergo an assessment of their symptoms by a physiotherapist or continence nurse. All patients are taught pelvic floor muscle training and men with urgency or urge incontinence are also taught bladder training. Pelvic floor training consists of 3 maximum pelvic floor contractions in 3 positions (standing, sitting, and lying down) twice a day, lifting of the pelvic floor while walking, tightening of the pelvic muscles before activities, and tightening of the pelvic muscles after urinating to squeeze out any last drops. The strength of the pelvic floor contractions is monitored by biofeedback involving digital anal assessment and relaying the information back to men in order that they know when they are performing contractions correctly and to inform them when they are increasing the strength or duration of their contractions. Therapists may use machine-mediated biofeedback with an anal biofeedback probe at their discretion in addition to digital anal assessment. Bladder training consists of gradually delaying urination by pelvic floor muscle contraction and distracting activities to teach the bladder to hold increasing volumes of urine. Patients also receive a customized Pelvic Floor Exercise Booklet describing pelvic floor muscle training in addition to a customized Lifestyle Advice Booklet giving general lifestyle advice. Patients have reinforcement sessions at approximately 2, 6, and 12 weeks after the first appointment.
Arm II (control group): Patients receive a customized Lifestyle Advice Booklet containing supportive lifestyle advice only (without reference to pelvic floor muscle training) by mail following randomization. Patients do not receive formal assessment or treatment but will be able to access usual care and routine NHS services if they feel they need help, including written advice if this is part of routine hospital care.
All patients keep a urinary diary at 3, 6, 9, and 12 months that includes frequency of urination (day and night), daily episodes of incontinence and quantity of loss, daily use of pads, and the need to change clothing or bedding. A Health Care Utilization Questionnaire will be obtained at 3 and 9 months. Additional questionnaires are obtained at baseline and 6 and 12 months.
The use of NHS services, pads, and practice of pelvic floor muscle training is documented in both groups using information from questionnaires and Urinary Diaries.
Six months after the last patient has been recruited, a check for Scottish men only is performed to compare self-reported operations, diagnoses, and hospital admissions with centrally collected data to validate a proportion of the data.
After completion of study treatment, patients are followed at 6 and 12 months.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Nonmalignant Neoplasm, Prostate Cancer, Psychosocial Effects of Cancer and Its Treatment, Sexual Dysfunction, Urinary Incontinence
Keywords
sexual dysfunction, psychosocial effects of cancer and its treatment, prostate cancer, benign prostatic hyperplasia, urinary incontinence
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Phase 3
Allocation
Randomized
Enrollment
800 (Anticipated)
8. Arms, Groups, and Interventions
Intervention Type
Behavioral
Intervention Name(s)
exercise intervention
Intervention Type
Other
Intervention Name(s)
questionnaire administration
Intervention Type
Procedure
Intervention Name(s)
biofeedback
Intervention Type
Procedure
Intervention Name(s)
management of therapy complications
Intervention Type
Procedure
Intervention Name(s)
psychosocial assessment and care
Intervention Type
Procedure
Intervention Name(s)
quality-of-life assessment
Primary Outcome Measure Information:
Title
Subjective report of urinary continence at 12 months
Title
Incremental cost per quality-adjusted year
Secondary Outcome Measure Information:
Title
Subjective report of continence or improvement of urinary incontinence at 3, 6, and 9 months after randomization and improvement at 12 months
Title
Objective report of the number of incontinent episodes in the previous week from the urinary diary
Title
Duration of incontinence based on time of resolution relative to time of operation and randomization
Title
Use of absorbent pads, penile collecting sheath, bladder catheter, or bed/chair pads
Title
Number and type of incontinence products used
Title
Co-existence, cure or development of urgency, or urge incontinence
Title
Urinary frequency
Title
Nocturia
Title
Fecal incontinence (passive or urge)
Title
Other bowel dysfunction (i.e., urgency, constipation, or other bowel diseases)
Title
Sexual function at 12 months including information about erection, ejaculation, retrograde ejaculation, pain, change in sex life, and reason for change
Title
Incontinence-specific quality of life outcome measure using the 10-point scale and ICI questionnaire
Title
General health measures
Title
Need for alternative management for incontinence (e.g., surgery or drugs)
Title
Use of GP, nurse, consultant urologist, or physiotherapist
Title
Visits to GP
Title
Visits to practice nurse
Title
Use of pelvic floor muscle training
Title
Lifestyle changes (i.e., weight, constipation, lifting, coughing, or exercise)
Title
Patient costs (e.g., self care [e.g., pads or laundry], travel to health services, or sick leave)
Title
Cost of conservative trial treatment
Title
Cost of alternative or additional NHS treatments (e.g., pads, catheters, drugs [e.g., adrenergic agonists, anticholinergics, or oral medication for erectile dysfunction], hospital admissions, or further surgery)
Title
Other measures of cost-effectiveness (e.g., incremental cost per additional man continent at 12 months)
10. Eligibility
Sex
Male
Accepts Healthy Volunteers
No
Eligibility Criteria
DISEASE CHARACTERISTICS:
Men who have undergone a radical prostatectomy for prostate cancer or men who have undergone a transurethral resection of the prostate for benign prostatic hypertrophy
Urinary incontinence at six weeks after prostate surgery
Incontinence is defined as a response on the screening questionnaire indicating a loss of urine including how often and how much
PATIENT CHARACTERISTICS:
Able to comply with intervention
Able to complete study questionnaires
PRIOR CONCURRENT THERAPY:
See Disease Characteristics
No referral for formal therapy (teaching of pelvic floor muscle training) due to prostate surgery
No concurrent or planned radiotherapy during the first 3 months after surgery
No palliative endoscopic resection of prostate due to outflow obstruction for advanced prostate cancer
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Cathryn Glazener, MD
Organizational Affiliation
Aberdeen Royal Infirmary
Official's Role
Study Chair
Facility Information:
Facility Name
Tameside General Hospital
City
Ashton-Under-Lyne
State/Province
England
ZIP/Postal Code
OL6 9RW
Country
United Kingdom
Facility Name
Southmead Hospital
City
Bristol
State/Province
England
ZIP/Postal Code
BS10 5NB
Country
United Kingdom
Facility Name
Bristol Royal Infirmary
City
Bristol
State/Province
England
ZIP/Postal Code
BS2 8HW
Country
United Kingdom
Facility Name
Mid Cheshire Hospitals Trust- Leighton Hopsital
City
Crewe
State/Province
England
ZIP/Postal Code
CW1 4QJ
Country
United Kingdom
Facility Name
Royal Bolton Hospital
City
Farnworth
State/Province
England
ZIP/Postal Code
BL4 0JR
Country
United Kingdom
Facility Name
King George Hospital
City
Ilford, Essex
State/Province
England
ZIP/Postal Code
IG3 8YB
Country
United Kingdom
Facility Name
Ipswich Hospital
City
Ipswich
State/Province
England
ZIP/Postal Code
IP4 5PD
Country
United Kingdom
Facility Name
Airedale General Hospital
City
Keighley
State/Province
England
ZIP/Postal Code
BD20 6TD
Country
United Kingdom
Facility Name
Leeds Cancer Centre at St. James's University Hospital
City
Leeds
State/Province
England
ZIP/Postal Code
LS9 7TF
Country
United Kingdom
Facility Name
St. Mary's Hospital
City
London
State/Province
England
ZIP/Postal Code
W2 1NY
Country
United Kingdom
Facility Name
Macclesfield District General Hospital
City
Macclesfield
State/Province
England
ZIP/Postal Code
SK10 3BL
Country
United Kingdom
Facility Name
James Cook University Hospital
City
Middlesbrough
State/Province
England
ZIP/Postal Code
TS4 3BW
Country
United Kingdom
Facility Name
Freeman Hospital
City
Newcastle-Upon-Tyne
State/Province
England
ZIP/Postal Code
NE7 7DN
Country
United Kingdom
Facility Name
Norfolk and Norwich University Hospital
City
Norwich
State/Province
England
ZIP/Postal Code
NR4 7UY
Country
United Kingdom
Facility Name
Nottingham City Hospital
City
Nottingham
State/Province
England
ZIP/Postal Code
NG5 1PB
Country
United Kingdom
Facility Name
Berkshire Cancer Centre at Royal Berkshire Hospital
City
Reading
State/Province
England
ZIP/Postal Code
RG1 5AN
Country
United Kingdom
Facility Name
Queens Hospital
City
Romford
State/Province
England
ZIP/Postal Code
RM3 0BE
Country
United Kingdom
Facility Name
Hope Hospital
City
Salford
State/Province
England
ZIP/Postal Code
M6 8HD
Country
United Kingdom
Facility Name
Royal Hallamshire Hospital
City
Sheffield
State/Province
England
ZIP/Postal Code
S1O 2JF
Country
United Kingdom
Facility Name
Lister Hospital
City
Stevenage
State/Province
England
ZIP/Postal Code
SG1 4AB
Country
United Kingdom
Facility Name
Stepping Hill Hospital
City
Stockport
State/Province
England
ZIP/Postal Code
SK2 7JE
Country
United Kingdom
Facility Name
Taunton and Somerset Hospital
City
Taunton
State/Province
England
ZIP/Postal Code
TA1 5DA
Country
United Kingdom
Facility Name
Hillingdon Hospital
City
Uxbridge
State/Province
England
ZIP/Postal Code
UB8 3NN
Country
United Kingdom
Facility Name
New Cross Hospital
City
Wolverhampton
State/Province
England
ZIP/Postal Code
WV10 0QP
Country
United Kingdom
Facility Name
Yeovil District Hospital
City
Yeovil
State/Province
England
ZIP/Postal Code
BA21 4AT
Country
United Kingdom
Facility Name
Aberdeen Royal Infirmary
City
Aberdeen
State/Province
Scotland
ZIP/Postal Code
AB25 2ZN
Country
United Kingdom
Facility Name
Ayr Hospital
City
Ayr
State/Province
Scotland
ZIP/Postal Code
KA6 6DX
Country
United Kingdom
Facility Name
Ninewells Hospital
City
Dundee
State/Province
Scotland
ZIP/Postal Code
DD1 9SY
Country
United Kingdom
Facility Name
Queen Margaret Hospital - Dunfermline
City
Dunfermline
State/Province
Scotland
ZIP/Postal Code
KY12 0SU
Country
United Kingdom
Facility Name
Edinburgh Cancer Centre at Western General Hospital
City
Edinburgh
State/Province
Scotland
ZIP/Postal Code
EH4 2XU
Country
United Kingdom
Facility Name
Falkirk and District Royal Infirmary
City
Falkirk
State/Province
Scotland
ZIP/Postal Code
FK1 5QE
Country
United Kingdom
Facility Name
Southern General Hospital
City
Glasgow
State/Province
Scotland
ZIP/Postal Code
G51 4TF
Country
United Kingdom
Facility Name
Inverclyde Royal Hospital
City
Greenock
State/Province
Scotland
ZIP/Postal Code
PA16 0XN
Country
United Kingdom
Facility Name
Raigmore Hospital
City
Inverness
State/Province
Scotland
ZIP/Postal Code
1V2 3UJ
Country
United Kingdom
Facility Name
Pinderfields General Hospital
City
Wakefield
State/Province
Scotland
ZIP/Postal Code
WF1 4DG
Country
United Kingdom
Facility Name
Morriston Hospital NHS Trust
City
West Glamorgen
State/Province
Scotland
ZIP/Postal Code
SA6 6NL
Country
United Kingdom
Facility Name
University Hospital of Wales
City
Cardiff
State/Province
Wales
ZIP/Postal Code
CF14 4XW
Country
United Kingdom
12. IPD Sharing Statement
Learn more about this trial
Pelvic Floor Muscle Training and Biofeedback or Standard Therapy in Men Who Have Undergone Radical Prostatectomy or Transurethral Resection of the Prostate
We'll reach out to this number within 24 hrs